GTS5:BRCA-related cancer predisposition syndrome (BRCA1, BRCA2): Difference between revisions
| [unchecked revision] | [unchecked revision] |
No edit summary |
No edit summary |
||
| Line 130: | Line 130: | ||
==Links== | ==Links== | ||
https://clinicalgenome.org/affiliation/50087/ | https://clinicalgenome.org/affiliation/50087/ | ||
https://www.ncbi.nlm.nih.gov/clinvar/?term=%22BRCA1%22%5BGENE%5D | |||
https://www.ncbi.nlm.nih.gov/clinvar/?term=%22BRCA2%22[GENE] | |||
==References== | ==References== | ||
<ref name=":0" />Petrucelli N, Daly MB, Pal T. BRCA1- and BRCA2-Associated Hereditary Breast and Ovarian Cancer. 1998 Sep 4 [updated 2025 Mar 20]. In: Adam MP, Bick S, Mirzaa GM, Pagon RA, Wallace SE, Amemiya A, editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993–2025. PMID: 20301425. | <ref name=":0" />Petrucelli N, Daly MB, Pal T. BRCA1- and BRCA2-Associated Hereditary Breast and Ovarian Cancer. 1998 Sep 4 [updated 2025 Mar 20]. In: Adam MP, Bick S, Mirzaa GM, Pagon RA, Wallace SE, Amemiya A, editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993–2025. PMID: 20301425. | ||